Our viability and EC50 data correlated with the STAT1 expression level of the parent tumor; however, the knowledge of the downstream signaling pathway(s) that certain TP53 mutations mediate JAK1/STAT1 overexpression and glioma-genesis is unknown. This evidence concerns the gene JAK1 and central nervous system cancer.